Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis

被引:118
作者
Herold, Tobias [1 ,2 ,3 ]
Schneider, Stephanie [1 ]
Metzeler, Klaus H. [1 ,2 ,3 ]
Neumann, Martin [1 ,2 ,3 ,4 ]
Hartmann, Luise [1 ,2 ,3 ]
Roberts, Kathryn G. [5 ]
Konstandin, Nikola P. [1 ]
Greif, Philipp A. [1 ,2 ,3 ]
Braeundl, Kathrin [1 ,2 ,3 ]
Ksienzyk, Bianka [1 ]
Huk, Natalia [1 ]
Schneider, Irene [1 ]
Zellmeier, Evelyn [1 ]
Jurinovic, Vindi [6 ]
Mansmann, Ulrich [6 ]
Hiddemann, Wolfgang [1 ,2 ,3 ]
Mullighan, Charles G. [5 ]
Bohlander, Stefan K. [7 ]
Spiekermann, Karsten [1 ,2 ,3 ]
Hoelzer, Dieter [8 ]
Bruggemann, Monika [9 ]
Baldus, Claudia D. [2 ,3 ,4 ]
Dreyling, Martin [1 ]
Goekbuget, Nicola [8 ]
机构
[1] LMU, Univ Hosp Grosshadern, Dept Internal Med 3, Munich, Germany
[2] German Canc Consortium DKTK, Heidelberg, Germany
[3] German Canc Res Ctr, Heidelberg, Germany
[4] Charite Univ Med Berlin, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany
[5] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA
[6] LMU, Inst Med Informat Biometry & Epidemiol, Munich, Germany
[7] Univ Auckland, Dept Mol Med & Pathol, Auckland, New Zealand
[8] Goethe Univ Hosp, Dept Med 2, Frankfurt, Germany
[9] Univ Hosp Schleswig Holstein, Dept Hematol, Campus Kiel, Kiel, Germany
关键词
READ ALIGNMENT; EXPRESSION; SIGNATURE; SUBGROUP; CHILDREN; SURVIVAL; DELETION; KINASE; IKZF1; MRD;
D O I
10.3324/haematol.2015.136366
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Philadelphia-like B-cell precursor acute lymphoblastic leukemia (Ph-like ALL) is characterized by distinct genetic alterations and inferior prognosis in children and younger adults. The purpose of this study was a genetic and clinical characterization of Ph-like ALL in adults. Twenty-six (13%) of 207 adult patients (median age: 42 years) with B-cell precursor ALL (BCP-ALL) were classified as having Ph-like ALL using gene expression profiling. The frequency of Ph-like ALL was 27% among 95 BCP-ALL patients negative for BCR-ABL1 and KMT2A-rearrangements. IGH-CRLF2 rearrangements (6/16; P=0.002) and mutations in JAK2 (7/16; P<0.001) were found exclusively in the Ph-like ALL subgroup. Clinical and outcome analyses were restricted to patients treated in German Multicenter Study Group for Adult ALL (GMALL) trials 06/99 and 07/03 (n=107). The complete remission rate was 100% among both Ph-like ALL patients (n=19) and the "remaining BCP-ALL" cases (n=40), i.e. patients negative for BCR-ABL1 and KMT2A-rearrangements and the Ph-like subtype. Significantly fewer Ph-like ALL patients reached molecular complete remission (33% versus 79%; P=0.02) and had a lower probability of continuous complete remission (26% versus 60%; P=0.03) and overall survival (22% versus 64%; P=0.006) at 5 years compared to the remaining BCP-ALL patients. The profile of genetic lesions in adults with Ph-like ALL, including older adults, resembles that of pediatric Ph-like ALL and differs from the profile in the remaining BCP-ALL. Our study is the first to demonstrate that Ph-like ALL is associated with inferior outcomes in intensively treated older adult patients. Ph-like adult ALL should be recognized as a distinct, high-risk entity and further research on improved diagnostic and therapeutic approaches is needed. (NCT00199056, NCT00198991)
引用
收藏
页码:130 / 138
页数:9
相关论文
共 26 条
[1]  
[Anonymous], R LANG ENV STAT COMP
[2]   BCR-ABL1-like cases in pediatric acute lymphoblastic leukemia: a comparison between DCOG/Erasmus MC and COG/St. Jude signatures [J].
Boer, Judith M. ;
Marchante, Joao R. M. ;
Evans, William E. ;
Horstmann, Martin A. ;
Escherich, Gabriele ;
Pieters, Rob ;
Den Boer, Monique L. .
HAEMATOLOGICA, 2015, 100 (09) :E354-E357
[3]   Expression profiling of adult acute lymphoblastic leukemia identifies a BCR-ABL1-like subgroup characterized by high non-response and relapse rates [J].
Boer, Judith M. ;
Koenders, Jasper E. ;
van der Holt, Bronno ;
Exalto, Carla ;
Sanders, Mathijs A. ;
Cornelissen, Jan J. ;
Valk, Peter J. M. ;
den Boer, Monique L. ;
Rijneveld, Anita W. .
HAEMATOLOGICA, 2015, 100 (07) :E261-E264
[4]   Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008 [J].
Brueggemann, M. ;
Schrauder, A. ;
Raff, T. ;
Pfeifer, H. ;
Dworzak, M. ;
Ottmann, O. G. ;
Asnafi, V. ;
Baruchel, A. ;
Bassan, R. ;
Benoit, Y. ;
Biondi, A. ;
Cave, H. ;
Dombret, H. ;
Fielding, A. K. ;
Foa, R. ;
Goekbuget, N. ;
Goldstone, A. H. ;
Goulden, N. ;
Henze, G. ;
Hoelzer, D. ;
Janka-Schaub, G. E. ;
Macintyre, E. A. ;
Pieters, R. ;
Rambaldi, A. ;
Ribera, J-M ;
Schmiegelow, K. ;
Spinelli, O. ;
Stary, J. ;
von Stackelberg, A. ;
Kneba, M. ;
Schrappe, M. ;
van Dongen, J. J. M. .
LEUKEMIA, 2010, 24 (03) :521-535
[5]   A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study [J].
Den Boer, Monique L. ;
van Slegtenhorst, Marjon ;
De Menezes, Renee X. ;
Cheok, Meyling H. ;
Buijs-Gladdines, Jessica G. C. A. M. ;
Peters, Susan T. C. J. M. ;
Van Zutven, Laura C. M. ;
Beverloo, H. Berna ;
Van der Spek, Peter J. ;
Escherich, Gaby ;
Horstmann, Martin A. ;
Janka-Schoub, Gritta E. ;
Kamps, Willem A. ;
Evans, William E. ;
Pieters, Rob .
LANCET ONCOLOGY, 2009, 10 (02) :125-134
[6]   Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies [J].
Goekbuget, Nicola ;
Kneba, Michael ;
Raff, Thorsten ;
Trautmann, Heiko ;
Bartram, Claus-Rainer ;
Arnold, Renate ;
Fietkau, Rainer ;
Freund, Mathias ;
Ganser, Arnold ;
Ludwig, Wolf-Dieter ;
Maschmeyer, Georg ;
Rieder, Harald ;
Schwartz, Stefan ;
Serve, Hubert ;
Thiel, Eckhard ;
Brueggemann, Monika ;
Hoelzer, Dieter .
BLOOD, 2012, 120 (09) :1868-1876
[7]   Global approach to the diagnosis of leukemia using gene expression profiling [J].
Haferlach, T ;
Kohlmann, A ;
Schnittger, S ;
Dugas, M ;
Hiddemann, W ;
Kern, W ;
Schoch, C .
BLOOD, 2005, 106 (04) :1189-1198
[8]   Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group [J].
Haferlach, Torsten ;
Kohlmann, Alexander ;
Wieczorek, Lothar ;
Basso, Giuseppe ;
Kronnie, Geertruy Te ;
Bene, Marie-Christine ;
De Vos, John ;
Hernandez, Jesus M. ;
Hofmann, Wolf-Karsten ;
Mills, Ken I. ;
Gilkes, Amanda ;
Chiaretti, Sabina ;
Shurtleff, Sheila A. ;
Kipps, Thomas J. ;
Rassenti, Laura Z. ;
Yeoh, Allen E. ;
Papenhausen, Peter R. ;
Liu, Wei-min ;
Williams, P. Mickey ;
Foa, Robin .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15) :2529-2537
[9]   Development and Validation Of a Highly Sensitive and Specific Gene Expression Classifier To Prospectively Screen and Identify B-Precursor Acute Lymphoblastic Leukemia (ALL) Patients With a Philadelphia Chromosome-Like ("Ph-like" or "BCR-ABL1-Like") Signature For Therapeutic Targeting and Clinical Intervention [J].
Harvey, Richard C. ;
Kang, Huining ;
Roberts, Kathryn G. ;
Chen, I-Ming L. ;
Atlas, Susan R. ;
Bedrick, Edward J. ;
Gastier-Foster, Julie M. ;
Zhang, Jinghui ;
Gerhard, Daniels S. ;
Smith, Malcolm A. ;
Larsen, Eric C. ;
Raetz, Elizabeth A. ;
Winick, Naomi J. ;
Carroll, William L. ;
Stonerock, Eileen ;
Heerema, Nyla A. ;
Carroll, Andrew J. ;
Chen, Shann-Ching ;
Song, Guangchun ;
Becksfort, Jared ;
Rusch, Michael ;
Li, Yongjin ;
Ma, Jing ;
Ell, Denise ;
Reshmi, Shalini C. ;
Loh, Mignon L. ;
Davidas, Meenakshi ;
Hunger, Stephen P. ;
Mullighan, Charles G. ;
Willman, Cheryl L. .
BLOOD, 2013, 122 (21)
[10]   An eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia [J].
Herold, T. ;
Jurinovic, V. ;
Metzeler, K. H. ;
Boulesteix, A-L ;
Bergmann, M. ;
Seiler, T. ;
Mulaw, M. ;
Thoene, S. ;
Dufour, A. ;
Pasalic, Z. ;
Schmidberger, M. ;
Schmidt, M. ;
Schneider, S. ;
Kakadia, P. M. ;
Feuring-Buske, M. ;
Braess, J. ;
Spiekermann, K. ;
Mansmann, U. ;
Hiddemann, W. ;
Buske, C. ;
Bohlander, S. K. .
LEUKEMIA, 2011, 25 (10) :1639-1645